Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    U.S. auto industry faces uncertainty without USMCA extension

    July 1, 2026

    Why is Neurogene stock sliding today?

    July 1, 2026

    Scientists find no link between Tylenol and autism, again, after Trump warning

    July 1, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Investing»Why is Klarna stock climbing today? By Investing.com
    Investing

    Why is Klarna stock climbing today? By Investing.com

    franperez66q@protonmail.comBy franperez66q@protonmail.comJuly 1, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    Investing.com — Klarna stock rose 3.8% in pre-open trading today, reaching $21, as event-driven interest around the scheduled publication of the PriceRunner antitrust verdict against Google — a ruling that courts had set specifically for July 1 — drew fresh buying interest into a stock that has been heavily beaten down from its post-IPO highs. The Klarna-Google antitrust verdict was specifically flagged as being set for July 1, making it a closely watched potential catalyst for the session. Klarna had previously notified investors that the Patent and Market Court in Stockholm had again postponed the judgment in the antitrust case brought by Klarna subsidiary PriceRunner against Google.

    On the analyst front, the picture heading into today is mixed but net constructive. Citizens initiated coverage on Klarna with a Market Perform rating, citing competitive pressures and noting that the company’s core Pay-in-X market faces significant competitive pressure due to relatively low barriers to entry in credit underwriting and capital requirements. However, this neutral stance is offset by more bullish voices: Freedom Capital initiated coverage with a Buy rating and a price target of $25.00, and according to 20 analysts, the average rating for KLAR stock is “Buy,” with a 12-month stock price target of $23.26.

    The broader market environment is providing a meaningful tailwind for fintech and growth names today. The S&P 500 is up 0.8%, the Dow Jones is gaining 0.3%, and the NASDAQ — home to many of Klarna’s closest peers — is advancing 1.5%, creating a risk-on backdrop that benefits higher-beta names. KLAR stock carries a beta coefficient of 2.07, meaning it tends to amplify broad market moves in both directions, and today’s positive tape is working squarely in its favor.

    Taken together, the convergence of a specific legal catalyst dated for today, a broadly supportive equity market, and a stock trading at a steep discount — KLAR reached its all-time high of $57.20 on September 10, 2025, and its all-time low of $12.06 on March 30, 2026 — has created conditions for a pre-market bounce. While the Citizens neutral initiation underscores real structural concerns around competition and growth sustainability, the stock’s compressed valuation relative to analyst targets appears to be drawing buyers on any positive headline.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Why is Neurogene stock sliding today?

    July 1, 2026

    Norsk Hydro to restart aluminium production at Slovalco plant

    July 1, 2026

    Why is JD Sports Fashion stock sliding today?

    July 1, 2026

    Volkswagen cuts are ’wake-up call’ for European industry, BYD advisor says

    July 1, 2026

    Japan stocks higher at close of trade; Nikkei 225 up 0.60%

    July 1, 2026

    Taiwan stocks higher at close of trade; Taiwan Weighted up 0.96%

    July 1, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    U.S. auto industry faces uncertainty without USMCA extension

    July 1, 2026

    Why is Neurogene stock sliding today?

    July 1, 2026

    Scientists find no link between Tylenol and autism, again, after Trump warning

    July 1, 2026

    Defence plan is '£5bn short', Badenoch says

    July 1, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.